Optimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
Amy Mottl, MD, MPH
Prof. Christoph Wanner
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
prof. Hiddo Heerspink
Jennifer B. Green, MD
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Bernhard Hellmich, MD
Elevating Care for Patients With Severe Renal Disease in AAV
Andreas Kronbichler, MD
Don't Miss It! Rapid & Accurate AAV Diagnosis
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Optimizing AAV Outcomes: Maintenance Therapies
Managing Patients With AAV in the Rheumatology Clinic
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Gates B. Colbert, MD
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Javed Butler, MD
Chiadi Ndumele, M.D., Ph.D., M.H.S.
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.